Observational study evaluates effective treatments for carbapenem-resistant Acinetobacter infections, suggesting implications for clinical practice.
Objective: To evaluate the efficacy of monotherapy versus combination therapy in the treatment of carbapenem-resistant Acinetobacter baumannii infections. Methods: A retrospective observational study was conducted in two tertiary hospitals in Brazil from 2018 to 2022. Patients diagnosed with bloodstream infections or ventilator-associated pneumonia caused by carbapenem-resistant Acinetobacter baumannii were included. Data on demographics, clinical characteristics, antimicrobial regimens, and outcomes […]
No takes yet. Share an insight, caveat, or question.
Bertholdi et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: